Literature DB >> 23472050

Vaccines in the Treatment of Substance Abuse.

Daryl Shorter1, Thomas R Kosten.   

Abstract

Reconceptualizing drugs as toxins allowed an important shift in the approach to the treatment of substance abuse, because it ushered in consideration of immunological methods of pharmacotherapy. This paradigm shift represented a dramatic departure from previously considered approaches to pharmacotherapy for substance use disorders (SUDs), which had up until that time focused predominantly on either agonist and/or antagonist medications meant to block drug effects or to decrease reward, reinforcement, or craving. Use of immunological theory in SUD treatment also meant that 1) a potentially addicting medication would not be administered as part of therapy and 2) side effects could be limited, because the individual's immune system would be responsible for delivering treatment.

Entities:  

Year:  2011        PMID: 23472050      PMCID: PMC3587968          DOI: 10.1176/foc.9.1.foc25

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  40 in total

Review 1.  A review of the clinical pharmacology of methamphetamine.

Authors:  Christopher C Cruickshank; Kyle R Dyer
Journal:  Addiction       Date:  2009-04-29       Impact factor: 6.526

Review 2.  Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors.

Authors:  Benito Anton; Alberto Salazar; Anabel Flores; Maura Matus; Rodrigo Marin; Jorge-Alberto Hernandez; Philippe Leff
Journal:  Hum Vaccin       Date:  2009-04-08

Review 3.  Disrupting nicotine reinforcement: from cigarette to brain.

Authors:  Jed E Rose
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 4.  Respiratory complications of cocaine abuse.

Authors:  J A Perper; D H Van Thiel
Journal:  Recent Dev Alcohol       Date:  1992

5.  A national evaluation of treatment outcomes for cocaine dependence.

Authors:  D D Simpson; G W Joe; B W Fletcher; R L Hubbard; M D Anglin
Journal:  Arch Gen Psychiatry       Date:  1999-06

6.  Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.

Authors:  J L Valentine; S M Owens
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

Review 7.  Immunotherapy for the treatment of drug abuse.

Authors:  Thomas Kosten; S Michael Owens
Journal:  Pharmacol Ther       Date:  2005-10       Impact factor: 12.310

8.  Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women.

Authors:  Judith A Cook; Jane K Burke-Miller; Mardge H Cohen; Robert L Cook; David Vlahov; Tracey E Wilson; Elizabeth T Golub; Rebecca M Schwartz; Andrea A Howard; Claudia Ponath; Michael W Plankey; Alexandra M Levine; Andrea Levine; Dennis D Grey
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

9.  A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents.

Authors:  Benito Anton; Philippe Leff
Journal:  Vaccine       Date:  2006-02-08       Impact factor: 3.641

10.  Engineering and characterization of a mouse/human chimeric anti-phencyclidine monoclonal antibody.

Authors:  H Marie Lacy; Melinda G Gunnell; Elizabeth M Laurenzana; S Michael Owens
Journal:  Int Immunopharmacol       Date:  2007-10-23       Impact factor: 4.932

View more
  2 in total

1.  Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques.

Authors:  Suzette M Evans; Richard W Foltin; Martin J Hicks; Jonathan B Rosenberg; Bishnu P De; Kim D Janda; Stephen M Kaminsky; Ronald G Crystal
Journal:  Pharmacol Biochem Behav       Date:  2016-09-30       Impact factor: 3.533

Review 2.  Vaccines against Drug Abuse-Are We There Yet?

Authors:  Benedict T Bloom; Mary-Jessimine Bushell
Journal:  Vaccines (Basel)       Date:  2022-05-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.